Ads
related to: Stelara- Patient Resources
Information About Injecting
Cost Support and More
- Cost Support Information
Learn About Cost Support Options
View Support Program Info.
- Save on STELARA®
Eligible Patients pay $5 copay/dose
2020 additional requirements apply
- About STELARA®
Information on Getting Started
Learn More About STELARA® Today
- Patient Resources
Search results
J&J’s Tremfya superior to Stelara in Phase II/III Chron’s disease trials
Clinical Trials Arena via Yahoo Finance· 1 week agoJohnson and Johnson’s Johnson and Johnson’s Tremfya (guselkumab) was superior to its Stelara...
Stelara biosimilar from Alvotech, Teva approved by FDA
BioPharma Dive via Yahoo Finance· 1 month agoDive Brief: Alvotech and Teva on Tuesday won Food and Drug Administration approval for Selarsdi, the...
Amgen settles patent lawsuit over biosimilar of J&J's big-selling Stelara
Reuters via Yahoo Finance· 1 year ago(Reuters) -Johnson & Johnson has settled its lawsuit over Amgen Inc's proposed biosimilar version of...
From Nurse To Patient: My Journey With Crohn’s Disease
Women's Health via Yahoo News· 2 years agoAs a healthcare professional, Alison spent her days doing endoscopies, which are one of the many...
Bellwether Health Giant J&J Skids As Psoriasis Blockbuster Drags Top Line
Investor's Business Daily· 1 month agoJohnson & Johnson stock skidded early Tuesday after light sales of blockbuster psoriasis treatment...
Alvotech settles with J&J to launch Stelara biosimilar in Europe, Canada
Reuters via Yahoo News· 3 months agoThe deals allow Alvotech's biosimilar, or near copies of a biological drug, to enter the Canadian...
Will J&J (JNJ) Pharma Unit Outperform Market & Drive Q1 Results?
Zacks via Yahoo Finance· 1 year agoIn J&J's (JNJ) Pharma segment, its oncology drug, Darzalex as well as a psoriasis treatment, Stelara...
Are your prescription drugs affordable? Colorado board wants feedback on these 2
KDVR Denver via Yahoo News· 1 month agoDENVER (KDVR) — A Colorado board continues reviewing the cost of prescription drugs, and public...
Johnson & Johnson forecasts as much as 6% sales growth in 2024
Reuters via Yahoo Finance· 6 months ago(Reuters) -Johnson & Johnson on Tuesday forecast revenue growth of 5-6% for 2024, its first full...
J&J's medical device sales fall short, cancer drugs seen growing
Reuters via AOL· 1 month ago(Reuters) -Johnson & Johnson's first-quarter revenue missed Wall Street estimates for medical...
Ads
related to: Stelara